Brief: Capital Cell, a Biotech Crowdfunding Platform, Receives Regulatory Approval in Spain
Capital Cell, an investment crowdfunding platform that describes itself as the first European crowdfunding platform for biotech projects, has recieved regulatory approval from the Comisión Nacional del Mercado de Valores (CNMV). According to a statement on their site, after ten months of audits, interviews and… Read More
Read more in: Investment Platforms and Marketplaces, Global | Tagged biotech, capital cell, daniel oliver, spain